project id: TCGA-LUAD; case submitter id: TCGA-50-5049; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; rna integrity number: 8.3; spectrophotometer method: UV Spec; age at index: 70; days to birth: -25577; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 25577; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3094.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.5; longest dimension: 2.0; preservation method: Unknown; shortest dimension: 0.3; sample id: 21b2f32e-ccea-4b20-86d3-6647e99825cf; sample submitter id: TCGA-50-5049-01A; portion id: 8b57a42a-5c6b-4d81-8926-dec16dbc02a3; portion submitter id: TCGA-50-5049-01A-01; percent necrosis: 3.0; percent normal cells: 10.0; percent stromal cells: 30.0; percent tumor cells: 57.0;